Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 1/20 | 0.40 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.40 |
| ▸ | FPR2 | P25090 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.31 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5172333 | 0.83 | TSHR (0.33) | GRM2GRM3FPR2TSHRALDH1A1 | |
| SCHEMBL2474898 | 0.77 | GRM2 (0.41) | GRM2GRM3FPR2ALDH1A1GAA | |
| SCHEMBL11337283 | 0.74 | CYP2C19 (0.48) | GRM2GRM3FPR2TSHRALDH1A1 | |
| SCHEMBL16824156 | 0.74 | GRM2 (0.38) | GRM2GRM3FPR2TSHRALDH1A1 | |
| SCHEMBL6058507 | 0.74 | MMP8 (0.44) | GRM2GRM3FPR2TSHRALDH1A1 | |
| SCHEMBL301722 | 0.74 | ACACB (0.40) | GRM2GRM3FPR2TSHRALDH1A1 | |
| SCHEMBL6120645 | 0.73 | TSHR (0.42) | TSHRALDH1A1CYP2C19CYP2D6HIF1A | |
| SCHEMBL8495466 | 0.72 | TSHR (0.43) | GRM2GRM3FPR2TSHRALDH1A1 | |
| SCHEMBL3248330 | 0.72 | TSHR (0.43) | GRM2GRM3FPR2TSHRALDH1A1 | |
| SCHEMBL3565109 | 0.72 | TSHR (0.43) | GRM2GRM3FPR2TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2391598-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF CHOLINE SALT OF FENOFIBRIC ACID AND ITS NOVEL POLYMORPH | Alembic Limited (IN) | 2011-12-07 | — | — | EP | disclosed |
| US-20110288331-A1 | PROCESS FOR THE PREPARATION OF CHOLINE SALT OF FENOFIBRIC ACID AND ITS NOVEL POLYMORPH | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2011-11-24 | — | — | US | disclosed |
| WO-2010086700-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF CHOLINE SALT OF FENOFIBRIC ACID AND ITS NOVEL POLYMORPH | ALEMBIC LIMITED (IN) | 2010-08-05 | — | — | WO | disclosed |
| EP-0582441-A1 | Processes for the preparation of tyramine derivatives | CHEMAGIS LTD. (IL) | 1994-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288331-A1 | PROCESS FOR THE PREPARATION OF CHOLINE SALT OF FENOFIBRIC ACID AND ITS NOVEL POLYMORPH | CHKB, HMGCR, CEL | GRM2 3318/4885GRM3 3322/4885FPR2 2674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.